European Archives - Page 399 of 1051 - European Medical Journal

Broadening our Understanding for Timely Diagnosis and Optimal Treatment of Erectile Dysfunction in COVID-19 Era

The world of sexual health and sexual medicine is rapidly growing with greater awareness on human sexuality, and the integration of novel technologies in healthcare practices.

Are MSLs ready for the spotlight?

How can the industry empower MSLs as they do sales reps?

Value-Based Radiology: A New Focus to Optimise Impact

Doctors have always liked to believe that what they do benefits their patients. It is, after all, intrinsic to our mission to “first, do no harm.” Over the centuries, however, doctors have not always achieved this goal.

Regenerative Medicine: Generating Discussion

In this week’s episode, Jonathan Sackier explores the history and uses of regenerative medicine while highlighting its different to transplantation.

The Evolving Landscape of Diabetes Care: Technological Advances to Biosimilars

With the incidence of diabetes rising annually across the globe to an estimated 537 million adults, healthcare expenditure is also rising.

Laying the Foundation Towards Long-Term Survival in Patients with High-Risk Acute Myeloid Leukaemia

For many patients diagnosed with acute myeloid leukaemia (AML), long-term survival remains elusive….

EMJ Hepatology 10.1 Feature Image

EMJ Hepatology 10.1 2022

Welcome to our latest issue of EMJ Hepatology. This journal provides in depth insight into the latest updates in Hepatology through research articles, independent reviews, and novel features.

EMJ Hepatology 10.1 Feature Image

Review of the European Association for the Study of Liver (EASL) International Liver Congress (ILC) 2022 Congress

AFTER a 3-year wait to meet in-person since the 2019 congress in Vienna, Austria, the European Association for the Study of Liver (EASL) International Liver Congress (ILC) took place in London, UK, from 22nd–26th June 2022. This year marked the 57th anniversary of the annual ILC event, and welcomed over 5,300 delegates on site, and over 1,300 virtually from 112 countries.

EMJ Hepatology 10.1 Feature Image

Holistic Patient Care in Primary Biliary Cholangitis

PBC is an immune-mediated, chronic, progressive liver disease characterised by gradual destruction of intrahepatic bile ducts.

EMJ Hepatology 10.1 Feature Image

Prescription Event Monitoring of Checkpoint Inhibitor-Induced Liver Injury and Outcomes of Rechallenge: A 10-Year Experience

The definition and severity of checkpoint inhibitor-induced liver injury (ChILI) have been reported using the Common Terminology Criteria for Adverse Events (CTCAE) used in cancer therapy.